High Tower Advisors, LLC Eli Lilly & CO Call Options Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $154,428 - $192,004	-200 Reduced 50.0%	200 $177,000
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $7.18 Million - $9 Million	-9,900 Reduced 96.12%	400 $362,000
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $6.1 Million - $8.16 Million	10,300 New	10,300 $8.01 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $233,985 - $290,785	-997 Reduced 99.7%	3 $7,000
Q1 2020 May 21, 2020	BUY	$119.05 - $147.35 $119,050 - $147,350	1,000 New	1,000 $7,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.